HUVEC were used in this in vitro study as a phenotypically homogeneous surrogate for true tumor endothelial cells because HUVEC recapitulate an embryonic vascular program resembling tumor endothelial cells with very low or absent expression of adhesion molecules [3,15,16], and constitutively express VEGFR2. The gene discussed is KDR; the disease is neoplasm.